Publikationen in Zusammenarbeit mit Forschern von Hospital Vall d'Hebron (15)

2024

  1. Lung Function and Symptoms of Exposure to the Volcanic Eruption in the Canary Islands: First Follow-Up of the ASHES Study

    Archivos de Bronconeumologia, Vol. 60, Núm. 8, pp. 475-482

  2. The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium

    Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 352-362

2023

  1. A longitudinal and multidesign epidemiological study to analyze the effect of the volcanic eruption of Tajogaite volcano (La Palma, Canary Islands). The ASHES study protocol

    Environmental Research, Vol. 216

  2. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

2022

  1. Analysis of Exposure and Respiratory Health Effects of Volcanic Eruption in the Canary Islands (ASHES). A SEPAR Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 11, pp. 780-782

  2. Development and Pilot Test of the Registry Evaluation and Quality Standards Tool: An Information Technology–Based Tool to Support and Review Registries

    Value in Health, Vol. 25, Núm. 8, pp. 1390-1398

  3. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

  2. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

    Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573

2018

  1. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding

    European Journal of Clinical Pharmacology, Vol. 74, Núm. 11, pp. 1503-1511

2011

  1. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: A case-control study

    PLoS ONE, Vol. 6, Núm. 5

2010

  1. Relation between temperature and mortality in thirteen Spanish cities

    International Journal of Environmental Research and Public Health, Vol. 7, Núm. 8, pp. 3196-3210

2009

  1. Prevalence of CYP2C9 polymorphisms in the south of Europe

    Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 306-310

2008

  1. CYP2D6-GENE POLYMORPHISMS ARE NOT RELATED TO INCREASED GASTROINTESTINAL HEMORRHAGE RISK IN USERS OF SSRI

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

  2. Prevalencia de infecciones por Acinetobacter baumannii resistente a carbapenemas en España (1999-2005)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 4, pp. 199-204